Table 2.
Association between overall response rate and main clinical-hematologic characteristics of multiple myeloma patients treated with elotuzumab plus pomaidomide and dexamethasone (N=193).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.